Breast cancer-related preferences among women with and without BRCA mutations

[1]  R. Steinbrook.  Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence. , 2008, The New England journal of medicine.

[2]  W. Hersh,et al.  Information on Cost-Effectiveness: An Essential Product of a National Comparative Effectiveness Program , 2008, Annals of Internal Medicine.

[3]  N. Kauff.  Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Stiggelbout,et al.  Health state utilities: a framework for studying the gap between the imagined and the real. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  E. Emanuel,et al.  Essential elements of a technology and outcomes assessment initiative. , 2007, JAMA.

[6]  Bruce L Daniel,et al.  Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. , 2006, JAMA.

[7]  A. Neugut,et al.  Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation , 2006, Annals of Internal Medicine.

[8]  G. Torrance.  Utility measurement in healthcare: the things I never got to. , 2006, PharmacoEconomics.

[9]  R. Calderon-Margalit,et al.  Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature , 2004, International journal of cancer.

[10]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[11]  W. Daal,et al.  Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation , 2004, British Journal of Cancer.

[12]  L. Fallowfield.  Evolution of breast cancer treatments: current options and quality-of-life considerations. , 2004, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[13]  J. Allanson,et al.  Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing , 2004, Quality of Life Research.

[14]  R. Kaplan.  The significance of quality of life in health care , 2004, Quality of Life Research.

[15]  A. Neugut,et al.  Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Stalmeier,et al.  Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. A'hern,et al.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews , 2001, BMJ : British Medical Journal.

[18]  A. Neugut,et al.  The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations. , 1999, The cancer journal from Scientific American.

[19]  C. Lindley,et al.  Perception of chemotherapy side effects cancer versus noncancer patients. , 1999, Cancer practice.

[20]  M. Gold,et al.  Panel on cost-effectiveness in health and medicine. , 1996, Medical care.

[21]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[22]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[23]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[24]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[25]  D. Feeny,et al.  Utilities and Quality-Adjusted Life Years , 1989, International Journal of Technology Assessment in Health Care.

[26]  G W Torrance,et al.  Utility approach to measuring health-related quality of life. , 1987, Journal of chronic diseases.

[27]  G. Torrance,et al.  The utility of different health states as perceived by the general public. , 1978, Journal of chronic diseases.